Mangoceuticals Inc
MGRX1.750USD
+0.040+2.34%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.750USD+1.750After-hours (ET)
12.50MMarket Cap
LossP/E TTM
Mangoceuticals Inc
1.750
+0.040+2.34%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Total revenue
-48.95%109.31K
-56.93%105.25K
-45.60%133.37K
15.52%163.16K
112.56%214.09K
2633.80%244.37K
--245.16K
--141.24K
--100.72K
--8.94K
--0.00
Revenue
-48.95%109.31K
-56.93%105.25K
-45.60%133.37K
15.52%163.16K
112.56%214.09K
2633.80%244.37K
--245.16K
--141.24K
--100.72K
--8.94K
--0.00
Cost of revenue
-29.17%47.24K
633.54%746.68K
-49.59%50.70K
72.57%93.37K
53.25%66.70K
2389.39%101.79K
--100.57K
--54.11K
--43.52K
--4.09K
--0.00
Operating expenses
92.22%4.96M
-10.95%2.50M
-7.49%1.89M
-4.18%2.33M
-2.94%2.58M
313.11%2.81M
106.15%2.04M
--2.43M
--2.66M
--680.79K
--991.83K
Depreciation, depletion, and amortization
6567.61%414.99K
-95.95%255.00
-95.99%252.00
-48.51%3.21K
2.33%6.22K
62.85%6.29K
--6.29K
--6.22K
--6.08K
--3.86K
----
Operating profit
-104.98%-4.85M
6.58%-2.40M
2.30%-1.76M
5.39%-2.17M
7.48%-2.37M
-282.23%-2.57M
-81.43%-1.80M
---2.29M
---2.56M
---671.86K
---991.83K
Net non-operating interest income (expenses)
Non-operating interest income
----
--450.60K
----
----
----
----
--0.00
--8.23K
----
----
----
Non-operating interest expense
----
----
--241.62K
--222.68K
-100.00%0.00
259.61%6.47K
----
----
--1.76K
--1.80K
--3.09K
Other non-operating income (expenses)
----
----
----
----
----
--6.47K
----
----
----
----
----
Income before tax
-104.40%-4.84M
24.12%-1.95M
-11.13%-2.00M
-4.70%-2.39M
7.55%-2.37M
-281.21%-2.57M
-80.87%-1.80M
---2.28M
---2.56M
---673.65K
---994.91K
Income tax
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
-104.40%-4.84M
24.12%-1.95M
-11.13%-2.00M
-4.70%-2.39M
7.55%-2.37M
-281.21%-2.57M
-80.87%-1.80M
---2.28M
---2.56M
---673.65K
---994.91K
Net income from continuous operations
-104.40%-4.84M
24.12%-1.95M
-11.13%-2.00M
-4.70%-2.39M
7.55%-2.37M
-281.21%-2.57M
-80.87%-1.80M
---2.28M
---2.56M
---673.65K
---994.91K
Net Income attributable to non-controlling interests
-172.22%-98.00
---244.00
---461.00
---340.00
---36.00
----
----
----
----
----
----
Net income attributable to controlling interests
-104.40%-4.84M
24.13%-1.95M
-11.10%-2.00M
-4.68%-2.39M
7.55%-2.37M
-281.21%-2.57M
-80.87%-1.80M
---2.28M
---2.56M
---673.65K
---994.91K
Net income attributable to common shareholders
-104.40%-4.84M
24.13%-1.95M
-11.10%-2.00M
-4.68%-2.39M
7.55%-2.37M
-281.21%-2.57M
-80.87%-1.80M
---2.28M
---2.56M
---673.65K
---994.91K
Basic earnings per share
32.26%-1.05
62.02%-0.74
-776.03%-14.85
36.74%-1.37
54.41%-1.56
-235.34%-1.96
-96.68%-1.70
---2.17
---3.41
---0.58
---0.86
Diluted earnings per share
32.26%-1.05
62.02%-0.74
-776.03%-14.85
36.74%-1.37
54.41%-1.56
-235.34%-1.96
-96.68%-1.70
---2.17
---3.41
---0.58
---0.86
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
